The University of British Columbia, in Vancouver, BC has selected the MILabs VECTor/CT system to further its brain research programs and to also perform important new work in oncology. The VECTor/CT will be placed in the new UBC Centre of Comparative Medicine Facility. The CCM facility is located next to TRIUMF, Canada’s national laboratory for nuclear and particle physics research, which houses the radiochemistry facilities associated with imaging. Novel radiotracer production will be performed at TRIUMF, which is owned and operated as a joint venture by a consortium of universities and is at the international vanguard of scientific innovation and discovery.
At UBC, VECTor/CT utilization will be led by Vesna Sossi, PhD, the Michael Smith Foundation for Health Research Senior Scholar and Imaging Director of the PET Programme. As the world’s first true simultaneous PET/SPECT system for preclinical imaging, the VECTor will be used by Professor Sossi and her team to perform more precise brain function analysis and continue their research into Parkinson’s Disease and oncology. With the VECTor/CT, the UBC group will explore new methods for examining brain function by imaging two (or more) processes simultaneously, such as perfusion and pharmacologically induced neurotransmitter release, by taking advantage of the multimodal acquisition capabilities that VECTor provides. Novel work in oncology will include multi-tracer tumour characterization.
